P4HA1 mediated high collagen deposition plays a crucial role in the tumor microenvironment and progression, and new therapeutic strategies or small-molecule inhibitors targeting collagen synthesis are being developed, which will be an important direction for future cancer research. The gene discussed is P4HA1; the disease is neoplasm.